TABLE 2.
Subject Group |
P |
|||||
---|---|---|---|---|---|---|
Parameter | E2/E2-N | E2/E2-H | E3/E2-H | E2/E2-N vs. E2/E2-H | E2/E2-N vs. E3/E2-H | E2/E2-H vs. E3/E2-H |
ApoB concentrations (mg/dl) | ||||||
VLDL | 4.01 ± 0.39 | 18.3 ± 3.76 | 18.3 ± 5.81 | 0.005 | 0.012 | 0.998 |
IDL | 5.10 ± 1.17 | 14.8 ± 3.05 | 7.73 ± 0.91 | 0.016 | 0.093 | 0.040 |
LDL | 28.0 ± 6.08 | 38.3 ± 6.56 | 84.6 ± 18.4 | 0.316 | 0.019 | 0.026 |
FCR (pools/day) | ||||||
VLDL | 2.57 ± 0.47 | 1.13 ± 0.20 | 1.52 ± 0.17 | 0.022 | 0.044 | 0.175 |
IDL | 1.15 ± 0.20 | 0.67 ± 0.11 | 0.83 ± 0.08 | 0.059 | 0.118 | 0.275 |
LDL | 0.70 ± 0.07 | 0.41 ± 0.06 | 0.38 ± 0.09 | 0.025 | 0.040 | 0.762 |
PR (mg/kg/day) | ||||||
VLDL | 4.78 ± 1.18 | 8.24 ± 1.29 | 11.5 ± 2.51 | 0.102 | 0.073 | 0.372 |
IDL | 2.78 ± 1.03 | 3.73 ± 0.30 | 2.83 ± 0.37 | 0.201 | 0.701 | 0.075 |
LDL | 8.88 ± 1.94 | 6.73 ± 1.03 | 12.8 ± 2.33 | 0.386 | 0.288 | 0.036 |
Conversion rate (%) | ||||||
VLDL to IDL | 65.6 ± 22.1 | 47.7 ± 4.26 | 31.2 ± 8,58 | 0.504 | 0.132 | 0.123 |
IDL to LDL | 43.8 ± 8.25 | 50.3 ± 4.52 | 80.1 ± 7.80 | 0.473 | 0.021 | 0.009 |
VLDL to LDL | 28.4 ± 11.7 | 23.3 ± 0.50 | 23.6 ± 5.03 | 0.702 | 0.672 | 0.949 |
VLDL apoB in slowly turning over compartment (%) | 9.80 ± 1.86 | 26.0 ± 2.95 | 7.69 ± 2.75 | 0.008 | 0.609 | 0.002 |
Direct LDL synthesis (%) | 85.8 ± 5.23 | 70.3 ± 3.72 | 80.2 ± 4.08 | 0.047 | 0.427 | 0.111 |
Data presented as mean ± SEM. Bold text indicates statistical significance a P < 0.05. N: normolipidemic; H: hyperlipidemic.